The founding team at Prologue Medicines (from L-R): CEO Lovisa Afzelius, chief scientific officer Hozefa Bandukwala, and president Theonie Anastassiadis
Flagship commits $50M to new startup that scours viral proteins for new drugs
In the midst of the Covid-19 pandemic, while most scientists were busy plotting new ways to combat viruses, one startup quietly began a counterintuitive campaign …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
